Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 9 ACAD Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
May 9 ACAD ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
May 9 AADI Aadi Bioscience First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.57 loss in 1Q 2023)
May 9 ACRV While institutions own 26% of Acrivon Therapeutics, Inc. (NASDAQ:ACRV), private equity firms are its largest shareholders with 50% ownership
May 9 ACAD ACADIA Pharmaceuticals Inc (ACAD) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue ...
May 9 ACAD ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript
May 9 ACAD ACADIA Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation
May 8 ABOS Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
May 8 ACAD Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
May 8 ACAD Acadia Pharma GAAP EPS of $0.10 beats by $0.05, revenue of $205.83M misses by $2.75M
May 8 ACAD Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
May 8 AADI Aadi Bioscience, Inc. (AADI) Q1 2024 Earnings Call Transcript
May 8 AADI Aadi Bioscience GAAP EPS of -$0.68 misses by $0.06, revenue of $5.4M misses by $1.29M
May 8 AADI Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update
May 8 ABOS Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
May 7 ACAD Acadia Pharma Q1 2024 Earnings Preview
May 7 ABOS Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024
May 7 AADI Aadi Bioscience Q1 2024 Earnings Preview
May 7 ABSI Absci (ABSI) to Report Q1 Earnings: Here's What to Expect
May 7 ABEO Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags